EUVIMEDEUVIMED entdecken
Open Access

Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer

Juan Wu, Yue Wang, Honglin Yan, Juanjuan Li, Chuntao Quan, Jingping Yuan, Shengrong Sun

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.081653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Juan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Aurora Kinase A, Breast Neoplasms, Protein Kinase Inhibitors, Erb-b2 Receptor Tyrosine Kinases. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aurora Kinase ABreast NeoplasmsProtein Kinase InhibitorsErb-b2 Receptor Tyrosine KinasesCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6HumansFemaleAnimalsMiceXenograft Model Antitumor AssaysDrug Resistance, NeoplasmMCF-7 CellsAminopyridinesBenzimidazolesCell Line, TumorCell ProliferationPhosphorylation

Stichwörter der Autor:innen

Aurora A kinaseCDK4/6i resistanceRB phosphorylationspindle assembly checkpointubiquitination

Substanzen

Aurora Kinase AProtein Kinase InhibitorsErb-b2 Receptor Tyrosine KinasesCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6AminopyridinesCDK6 protein, humanCDK4 protein, humanabemaciclibBenzimidazoles

Autor:innen und Institutionen

  • Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Oncology Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.
  • Department of Pathology, Biobank, Shenzhen Second People's Hospital, Shenzhen University, Shenzhen, China.

Zitieren

APA

Wu, J., Wang, Y., Yan, H., Li, J., Quan, C., Yuan, J., & Sun, S. (2026). Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.081653

Vancouver

Wu J, Wang Y, Yan H, Li J, Quan C, Yuan J, et al. Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.081653

BibTeX
@article{Wu2026,
  author = {Wu, Juan and Wang, Yue and Yan, Honglin and Li, Juanjuan and Quan, Chuntao and Yuan, Jingping and Sun, Shengrong},
  title = {Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.081653}
}
Kostenlos starten →